| Albumin in Acute Ischemic Stroke Trial |
ALIAS |
3 |
 |
| Simvastatin For Intracerebral Hemorrhage Study |
|
2 |
 |
| WENBIT - Western Norway B Vitamin Intervention Trial |
WENBIT |
3 |
 |
| Clopidogrel of loading dosage to treat acute ischaemic stroke in China |
CLASS-CHINA |
N/A |
 |
| PILL Pilot: Programme to Improve Life and Longevity |
|
N/A |
|
| A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke |
|
3 |
|
| A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension |
|
2 |
|
| Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke |
DIAS-3 |
3 |
|
| Vitamin D, Insulin Resistance, and Cardiovascular Disease |
|
N/A |
|
| Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH) |
|
1/2 |
|
| Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial |
STASH |
3 |
|
| REGENESIS (US): A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients |
REGENESIS |
2 |
 |
| Citicoline In Traumatic Brain Injury |
CITBRAIN |
N/A |
|
| Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4) |
|
3 |
|
| Neuroprotection with Statin Therapy for Acute Recovery Trial (Neu START):A Phase 2 safety and pilot efficacy study of lovastatin for the treatment of acute ischemic stroke [SPOTRIAS] |
NeuSTART II |
N/A |
|
| Enhancing Rehabilitation After Stroke |
Enhance |
3 |
|
| Lycopene Following Aneurysmal Subarachnoid Haemorrhage |
LASH |
2 |
 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) |
ACTIVE I |
3 |
|
| STroke imAging pRevention and Treatment-Extending the time for Thrombolysis in Emergency
Neurological Deficits
|
START-EXTEND |
N/A |
|
| Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease |
Polypill |
2 |
|
| Clazosentan in Aneurysmal Subarachnoid Hemorrhage |
CONSCIOUS-3 |
3 |
|
| Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients |
REGENESIS-LED |
2 |
|
| Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (Study P04737AM3) |
|
3 |
|
| Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial |
POINT |
3 |
|
| A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)(MK-6621-045) |
ACT V |
3 |
|
| IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb |
|
3 |
|
| Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578AM3)(COMPLETED) |
ENHANCE |
3 |
|
| Extending the Time for Thrombolysis in Emergency Neurological Deficits |
EXTEND |
3 |
|
| Safety Study of Dantrolene in Subarachnoid Hemorrhage |
|
1/2 |
|
| Aspirin in Reducing Events in the Elderly |
ASPREE |
4 |
|
| Stroke Treatment with Acute Reperfusion and Simvastatin |
STARS07 |
N/A |
|
| Safety Escalating Repeat IV, in Stroke Patients |
MAG111539 |
2 |
|
| Omega 3 Fatty Acids and Atrial Fibrillation |
|
N/A |
|
| A Randomized, Active Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization (CLOTBUSTER) in Acute Ischemic Stroke |
CLOTBUSTER |
3 |
|
| Fluoxetine on Motor Rehabilitation After Ischemic Stroke |
FLAME |
2 |
|
| Vitamin D and Omega-3 Trial (VITAL) |
VITAL |
N/A |
|
| Scandinavian Candesartan Acute Stroke Trial (SCAST) |
|
3 |
|
| Dapsone for Acute Ischemia Stroke Study |
DAISY |
2/3 |
|
| The Second Prevention Trial for Ischemic Stroke With Dengzhan Shengmai Capsule |
SPIRIT-DZSM-1 |
4 |
|
| Effects on Clinical and Functional Outcome of Escitalopram in Adult Stroke Patients |
|
4 |
|
| Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA) |
|
1/2 |
|
| Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke |
DIAS-J |
2 |
|
| Desmoteplase in Acute Ischemic Stroke (DIAS) |
|
2 |
|
| Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke |
|
2 |
|
| Study to Examine the Effects of MultiStem in Ischemic Stroke |
|
2 |
|
| Effectiveness and Safety of Angongniuhuang Pill on Restoring Consciousness for Patients Who Have Suffered From a Stroke |
|
2/3 |
|
| Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke |
|
1 |
|
| Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke |
|
1 |
|
| The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke |
|
0 |
|
| China Stroke Secondary Prevention Trial |
CSSPT |
N/A |
 |
| Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From a Stroke |
|
2 |
|
| Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity |
|
3 |
|
| Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity |
|
3 |
|
| Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke |
|
2 |
|
| Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS) |
DEDAS |
1/2 |
|
| Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic Stroke |
|
2 |
|
| Ginsenoside-Rd for Acute Ischemic Stroke |
|
2 |
|
| Efficacy of Folrex in the Superior Extremity Rehabilitation After Acute Stroke |
|
3 |
|
| Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke |
|
3 |
|
| Magnesium Chloride Versus Placebo in Patients Who Have Had a Stroke |
|
2/3 |
|
| Trial to Investigate the Influence of the Homeopathic Remedy Naja-comp on Stroke Therapy in Geriatric Rehabilitation |
naja-comp |
N/A |
|
| Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery |
|
2 |
|
| Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain |
|
4 |
|
| Extending Acute Stroke Trials to the Aerial Inter-Hospital Transfer Setting |
AirDoc |
N/A |
|
| Action of Amantadine on Post-Stroke Aphasic Patients |
CELIC-1 |
2/3 |
|
| Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke |
|
4 |
|
| Paramedic Initiated Lisinopril For Acute Stroke Treatment |
PIL-FAST |
1 |
|
| Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke |
|
2 |
|
| The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study) |
|
4 |
|
| Guanfacine for the Treatment of Spatial Neglect and Impaired Vigilance |
GASNIV |
2 |
|
| Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke? |
|
N/A |
|
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity |
|
3 |
|
| Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity |
|
4 |
|
| Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes |
NICE |
4 |
|
| Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke |
|
2/3 |
|
| Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables |
Electro |
2 |
|
| Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients With Acute Coronary Syndrome (TRA•CER) (Study P04736AM3) |
|
3 |
|
| Trial to Assess the Safety of SCH 530348 in Japanese Subjects With Cerebral Infarction (Study P05005AM5)(COMPLETED) |
|
2 |
|
| Dysport® Adult Lower Limb Spasticity Study |
|
3 |
|
| Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes |
CRESCENDO |
3 |
|
| Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease |
HUPrevent |
2 |
|
| Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill |
VASTVALUS |
2/3 |
|
| Enhancement of Motor Function With Reboxetine and Transcranial Direct Current Stimulation |
STIMBOX |
4 |
|
| Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications |
SAVOR- TIMI 53 |
4 |
|
| Memantine and Intensive Speech-Language Therapy in Aphasia |
|
4 |
|
| Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) |
CANTOS |
3 |
|
| Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans |
|
1/2 |
|
| PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin. |
|
3 |
|
| The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia |
|
N/A |
|
| Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes |
MELAS |
2 |
|
| TomVasc - Vascular Effects of Tomato Extract |
TomVasc |
N/A |
|
| Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome |
EXAMINE |
3 |
|
| Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia |
|
2 |
|
| Anti-MAG First Administration to Human |
|
1 |
|
| Supplementation of Lycopene in Carotid Atheroma |
SOLANUM |
N/A |
|
| Dysport® Adult Upper Limb Spasticity |
|
3 |
|
| Drug Interaction Between Paracetamol and Warfarin |
INPAWA2 |
4 |
|
| Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment |
|
2 |
|
| A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People |
APOLLO |
3 |
|
| Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine |
SEARCH |
3 |
|
| Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183AM1)(COMPLETED) |
|
3 |
|
| Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE) |
ALPINE |
2/3 |
|
| RIVastigmine In Vascular cognitivE Impairment |
RIVIVE |
4 |
|
| A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI) |
ATLANTIC |
4 |
|
| Secondary Prevention of Small Subcortical Strokes Trial |
SPS3 |
3 |
|
| Repinotan in Patients With Acute Ischemic Stroke |
|
2 |
|
| Sertraline for Preventing Post-Stroke Depression and Improving Rehabilitation Outcomes |
|
4 |
|
| Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2) |
|
3 |
|
| Insulin Resistance Intervention After Stroke Trial |
IRIS |
3 |
|
| Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI) |
|
2 |
|
| Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke |
|
3 |
|
| ICTUS Study: International Citicoline Trial on Acute Stroke |
ICTUS |
3 |
|
| Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST |
|
2 |
|
| Preventing Post-Stroke Depression |
|
3 |
|
| Transcranial Ultrasound in Clinical SONothrombolysis |
TUCSON |
1/2 |
|
| A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease |
ARRIVE |
3 |
|
| Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping |
CONSCIOUS-2 |
3 |
|
| Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke |
|
2 |
|
| ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke |
|
3 |
|
| Overcome Biochemical Aspirin Resistance Through Cilostazol Combination |
ARCC |
4 |
|
| Evaluating Neuroprotection in Aneurysm Coiling Therapy |
ENACT |
2 |
|
| A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation |
ATHENA |
3 |
|
| Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage |
|
N/A |
|
| The Spot Sign for Predicting and Treating ICH Growth Study |
STOP-IT |
2 |
|
| Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke |
MACSI |
3 |
|
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A) |
|
3 |
|
| Autologous Cell Therapy After Stroke |
|
1 |
|
| Donepezil Trial for Motor Recovery in Acute Stroke |
|
1/2 |
|
| Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment |
COGICRehab |
2 |
|
| Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke |
WAKE-UP |
3 |
|
| Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke |
|
0 |
|
| Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue |
|
4 |
|
| Use of Minocicline in Patients With Stroke |
|
1 |
|
| Escitalopram Treatment In Acute Stroke |
ESTIAS |
4 |
|
| EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International) |
EXTEND |
3 |
|
| Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI) |
ARTEMIDA |
3 |
|
| Cardiovascular Inflammation Reduction Trial |
CIRT |
4 |
|
